| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 3.82e-05 | 4 | 51 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 3.82e-05 | 4 | 51 | 2 | GO:0047655 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 9.53e-05 | 6 | 51 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | NADP+ binding | 2.28e-04 | 9 | 51 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 3.95e-04 | 56 | 51 | 3 | GO:0016830 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 5.71e-04 | 14 | 51 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 5.71e-04 | 14 | 51 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 6.57e-04 | 15 | 51 | 2 | GO:0052650 | |
| GeneOntologyMolecularFunction | vitamin binding | 7.58e-04 | 161 | 51 | 4 | GO:0019842 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 8.37e-04 | 793 | 51 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.18e-03 | 20 | 51 | 2 | GO:0004303 | |
| GeneOntologyMolecularFunction | proteasome binding | 1.18e-03 | 20 | 51 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | retinal binding | 1.30e-03 | 21 | 51 | 2 | GO:0016918 | |
| GeneOntologyMolecularFunction | transporter activity | TMEM120B TMEM120A SLC4A8 ASIC2 SLC25A33 TRPC5 TMEM184C TMC4 NIPAL3 SLC25A28 | 1.36e-03 | 1289 | 51 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | NADPH binding | 2.00e-03 | 26 | 51 | 2 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.16e-03 | 27 | 51 | 2 | GO:0008106 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TMEM120B TMEM120A SLC4A8 ASIC2 SLC25A33 TRPC5 TMC4 NIPAL3 SLC25A28 | 2.74e-03 | 1180 | 51 | 9 | GO:0022857 |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.02e-03 | 32 | 51 | 2 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.21e-03 | 33 | 51 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | carboxy-lyase activity | 3.81e-03 | 36 | 51 | 2 | GO:0016831 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 4.46e-03 | 39 | 51 | 2 | GO:0016229 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.19e-03 | 459 | 51 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.53e-03 | 465 | 51 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | retinoid binding | 6.69e-03 | 48 | 51 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 6.69e-03 | 48 | 51 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 6.97e-03 | 49 | 51 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 9.02e-03 | 56 | 51 | 2 | GO:0030170 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 9.02e-03 | 56 | 51 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 9.33e-03 | 57 | 51 | 2 | GO:0070279 | |
| MousePheno | abnormal intestine regeneration | 6.78e-05 | 5 | 37 | 2 | MP:0003380 | |
| MousePheno | impaired intestine regeneration | 6.78e-05 | 5 | 37 | 2 | MP:0031319 | |
| Domain | TMPIT | 7.31e-06 | 2 | 51 | 2 | IPR012926 | |
| Domain | TMPIT | 7.31e-06 | 2 | 51 | 2 | PF07851 | |
| Domain | Pyridoxal-P_BS | 7.27e-05 | 5 | 51 | 2 | IPR021115 | |
| Domain | Pyridoxal_deC | 2.03e-04 | 8 | 51 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 2.03e-04 | 8 | 51 | 2 | PS00392 | |
| Domain | PyrdxlP-dep_de-COase | 2.03e-04 | 8 | 51 | 2 | IPR002129 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.24e-04 | 10 | 51 | 2 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 3.24e-04 | 10 | 51 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.24e-04 | 10 | 51 | 2 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.24e-04 | 10 | 51 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.24e-04 | 10 | 51 | 2 | PS00063 | |
| Domain | - | 8.56e-04 | 16 | 51 | 2 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 9.68e-04 | 17 | 51 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 9.68e-04 | 17 | 51 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 9.68e-04 | 17 | 51 | 2 | IPR001395 | |
| Domain | - | 4.11e-03 | 35 | 51 | 2 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 4.34e-03 | 36 | 51 | 2 | IPR015422 | |
| Domain | - | 5.08e-03 | 39 | 51 | 2 | 3.40.640.10 | |
| Domain | PyrdxlP-dep_Trfase | 5.60e-03 | 41 | 51 | 2 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 5.60e-03 | 41 | 51 | 2 | IPR015421 | |
| Domain | ARM-like | 6.27e-03 | 270 | 51 | 4 | IPR011989 | |
| Domain | SOLCAR | 9.22e-03 | 53 | 51 | 2 | PS50920 | |
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 2.11e-06 | 2 | 51 | 2 | 33644071 | |
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 2.11e-06 | 2 | 51 | 2 | 34954342 | |
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 2.11e-06 | 2 | 51 | 2 | 25120755 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21087085 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8526877 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 36518763 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25538260 | ||
| Pubmed | TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation. | 2.11e-06 | 2 | 51 | 2 | 26024229 | |
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 2.11e-06 | 2 | 51 | 2 | 21276782 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31911858 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34465718 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 7578036 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8541228 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 7510692 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 25988357 | ||
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 6.32e-06 | 3 | 51 | 2 | 17381426 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 21179467 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 10092857 | ||
| Pubmed | TACAN Is an Ion Channel Involved in Sensing Mechanical Pain. | 2.10e-05 | 5 | 51 | 2 | 32084332 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 26291391 | ||
| Pubmed | 3.77e-05 | 44 | 51 | 3 | 30146317 | ||
| Pubmed | Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. | 4.41e-05 | 7 | 51 | 2 | 17965014 | |
| Pubmed | Daxx regulates mitotic progression and prostate cancer predisposition. | 5.87e-05 | 8 | 51 | 2 | 23239745 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 27177420 | ||
| Pubmed | Systematic identification of pathological lamin A interactors. | 1.35e-04 | 337 | 51 | 5 | 24623722 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.63e-04 | 186 | 51 | 4 | 33637726 | |
| Pubmed | Sox2-Evf2 lncRNA-mediated mechanisms of chromosome topological control in developing forebrain. | 1.63e-04 | 13 | 51 | 2 | 33593819 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 22051675 | ||
| Pubmed | 2.23e-04 | 1442 | 51 | 9 | 35575683 | ||
| Pubmed | 2.68e-04 | 212 | 51 | 4 | 19521566 | ||
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 22411552 | ||
| Pubmed | PELI1 Selectively Targets Kinase-Active RIP3 for Ubiquitylation-Dependent Proteasomal Degradation. | 3.55e-04 | 19 | 51 | 2 | 29883609 | |
| Pubmed | 4.47e-04 | 101 | 51 | 3 | 9872452 | ||
| Pubmed | 9.54e-04 | 31 | 51 | 2 | 27798109 | ||
| Pubmed | 1.10e-03 | 1440 | 51 | 8 | 30833792 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.41e-03 | 1155 | 51 | 7 | 20360068 | |
| Cytoband | 7q33 | 9.65e-04 | 41 | 51 | 2 | 7q33 | |
| Cytoband | Xq23 | 1.55e-03 | 52 | 51 | 2 | Xq23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q33 | 1.92e-03 | 58 | 51 | 2 | chr7q33 | |
| Cytoband | 12q24.31 | 3.62e-03 | 80 | 51 | 2 | 12q24.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq23 | 4.45e-03 | 89 | 51 | 2 | chrXq23 | |
| Cytoband | 7q11.23 | 5.27e-03 | 97 | 51 | 2 | 7q11.23 | |
| GeneFamily | Aldo-keto reductases | 2.57e-04 | 15 | 29 | 2 | 399 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.98e-03 | 181 | 29 | 3 | 694 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | 1.78e-06 | 588 | 51 | 9 | M38992 | |
| Coexpression | MANALO_HYPOXIA_DN | 2.15e-05 | 292 | 51 | 6 | M18562 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP | 4.35e-05 | 200 | 51 | 5 | M7077 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 4.35e-05 | 200 | 51 | 5 | M6653 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 4.35e-05 | 200 | 51 | 5 | M8620 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN | 4.35e-05 | 200 | 51 | 5 | M3882 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | 4.35e-05 | 200 | 51 | 5 | M3891 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_UP | 9.93e-05 | 46 | 51 | 3 | M4888 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.94e-07 | 130 | 51 | 5 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.54e-07 | 152 | 51 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.62e-06 | 191 | 51 | 5 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.69e-06 | 192 | 51 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.69e-06 | 192 | 51 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 193 | 51 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.21e-06 | 199 | 51 | 5 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 129 | 51 | 4 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 130 | 51 | 4 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 132 | 51 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.49e-05 | 148 | 51 | 4 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.77e-05 | 152 | 51 | 4 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | IIH-CD8-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.91e-05 | 154 | 51 | 4 | a2f51a3c5455fe2483e438375ea856afce8262fe | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.06e-05 | 156 | 51 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.14e-05 | 157 | 51 | 4 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.81e-05 | 165 | 51 | 4 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.48e-05 | 172 | 51 | 4 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.90e-05 | 176 | 51 | 4 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.90e-05 | 176 | 51 | 4 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 180 | 51 | 4 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.70e-05 | 183 | 51 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.70e-05 | 183 | 51 | 4 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.07e-05 | 186 | 51 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-05 | 187 | 51 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.20e-05 | 187 | 51 | 4 | e1d6c1194476cf26969e405b0951796fed519f44 | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 6.73e-05 | 191 | 51 | 4 | 32381d353e40bce77a5b63c7bdbe360d27327d86 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-05 | 191 | 51 | 4 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.73e-05 | 191 | 51 | 4 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.73e-05 | 191 | 51 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 7.01e-05 | 193 | 51 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.01e-05 | 193 | 51 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 194 | 51 | 4 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 194 | 51 | 4 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 7.29e-05 | 195 | 51 | 4 | 8679a122fe796b1eddef82460e985b3fd3b3a2a5 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 7.29e-05 | 195 | 51 | 4 | c60982804a74dbe6607c021799ca74af2204aba8 | |
| ToppCell | 11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 7.44e-05 | 196 | 51 | 4 | 2648d64b0e7b59ae78182d55f32699ceea37ff8d | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.44e-05 | 196 | 51 | 4 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.44e-05 | 196 | 51 | 4 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.44e-05 | 196 | 51 | 4 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.58e-05 | 197 | 51 | 4 | b044833de12f2b9eb702155563cd8932bc16e0ef | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.58e-05 | 197 | 51 | 4 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.58e-05 | 197 | 51 | 4 | 51340570667914bffec741c72a8d09cc46abb8e8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.73e-05 | 198 | 51 | 4 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.73e-05 | 198 | 51 | 4 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.73e-05 | 198 | 51 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.73e-05 | 198 | 51 | 4 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.73e-05 | 198 | 51 | 4 | db107a5511571384f26e26c6301aef9a9f2423c4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.89e-05 | 199 | 51 | 4 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.89e-05 | 199 | 51 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.89e-05 | 199 | 51 | 4 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.89e-05 | 199 | 51 | 4 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.04e-05 | 200 | 51 | 4 | 693adc310953b669c9b93e2e7a3346606f75c810 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 8.04e-05 | 200 | 51 | 4 | 42403d59b65d4b3ba6aa4aaf2d7252176067fba5 | |
| ToppCell | control-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.04e-05 | 200 | 51 | 4 | f8b5e5464b2ffef7b0ce75f60839c8ef791e17ba | |
| ToppCell | distal-Epithelial-Proliferating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-05 | 200 | 51 | 4 | cc31e8c28d01e6757c5dd7f485db6acf7409a47e | |
| ToppCell | distal-Epithelial-Proliferating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.04e-05 | 200 | 51 | 4 | 25cc494ef831511840d8c02ec1bd086635cc7edd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 100 | 51 | 3 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.26e-04 | 117 | 51 | 3 | 0602bbad908cb28c5093b74d717da5f2af577943 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.51e-04 | 120 | 51 | 3 | a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a | |
| ToppCell | Mild-Myeloid-Macrophages-|Mild / Condition, Lineage, Cell class and cell subclass | 3.68e-04 | 122 | 51 | 3 | b837456a6a236add2c0005cb3ca71568d631014e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-04 | 124 | 51 | 3 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.14e-04 | 127 | 51 | 3 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.85e-04 | 134 | 51 | 3 | d63fff23040eada31bc35ba1e05b7c6a663e0037 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.85e-04 | 134 | 51 | 3 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.17e-04 | 137 | 51 | 3 | 9324b55eac55e0cc1e8e450a4b5374d12e9587a3 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.17e-04 | 137 | 51 | 3 | 032f8409d0d179e254c8ff632afbda78852a9889 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.17e-04 | 137 | 51 | 3 | 265a4a50e48b13c8b3b0730f818235f71fbd6baa | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.60e-04 | 149 | 51 | 3 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-04 | 150 | 51 | 3 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 7.12e-04 | 153 | 51 | 3 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.26e-04 | 154 | 51 | 3 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.26e-04 | 154 | 51 | 3 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.68e-04 | 157 | 51 | 3 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.82e-04 | 158 | 51 | 3 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-04 | 159 | 51 | 3 | 0fbfdb18b7ed4bde077add13f2b3636e144b254f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.96e-04 | 159 | 51 | 3 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.96e-04 | 159 | 51 | 3 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.96e-04 | 159 | 51 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-Treg|ICU-NoSEP / Disease, Lineage and Cell Type | 7.96e-04 | 159 | 51 | 3 | d065ec02a4f3672ba53d4fea66029f1ce68f367f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.96e-04 | 159 | 51 | 3 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.11e-04 | 160 | 51 | 3 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.26e-04 | 161 | 51 | 3 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.26e-04 | 161 | 51 | 3 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-04 | 161 | 51 | 3 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.26e-04 | 161 | 51 | 3 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.26e-04 | 161 | 51 | 3 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-04 | 161 | 51 | 3 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.41e-04 | 162 | 51 | 3 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.56e-04 | 163 | 51 | 3 | 4dfd408aa700e307478ee35f6b902f68719d8d9e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.56e-04 | 163 | 51 | 3 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.56e-04 | 163 | 51 | 3 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.56e-04 | 163 | 51 | 3 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.56e-04 | 163 | 51 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-04 | 163 | 51 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.71e-04 | 164 | 51 | 3 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.86e-04 | 165 | 51 | 3 | 4297588f809e8a8275ab1a6ed99daac7ad93bd61 | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 7310_UP | |
| Disease | symmetrical dimethylarginine measurement | 9.26e-05 | 9 | 48 | 2 | EFO_0006523 | |
| Disease | age at menopause | 1.30e-04 | 302 | 48 | 5 | EFO_0004704 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 3.90e-04 | 18 | 48 | 2 | OBA_2045155 | |
| Disease | HDL cholesterol change measurement | 6.99e-04 | 24 | 48 | 2 | EFO_0007805 | |
| Disease | pneumonia, COVID-19 | 8.34e-04 | 113 | 48 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 9.46e-04 | 118 | 48 | 3 | EFO_0010119 | |
| Disease | stomach cancer (is_marker_for) | 1.61e-03 | 142 | 48 | 3 | DOID:10534 (is_marker_for) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.66e-03 | 37 | 48 | 2 | EFO_0007645, EFO_0009458 | |
| Disease | unipolar depression, bipolar disorder | 2.11e-03 | 156 | 48 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | glycerophospholipid measurement | 2.90e-03 | 49 | 48 | 2 | EFO_0007630 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YCLLLFYKVLKEELS | 226 | Q9NVA4 | |
| YCIKREYLICEDYKL | 766 | O60566 | |
| IPCKRLFEYILLYKD | 86 | Q9UM22 | |
| LCKYYEKRLLEFCSV | 56 | P51946 | |
| TLKDLKLSYLDVYLI | 96 | O60218 | |
| AKLYVYINELCTVLK | 121 | Q9UER7 | |
| TLKKLLLLVCFLDYA | 886 | Q8IZT6 | |
| FDYIYELIKEKLLDL | 451 | Q16515 | |
| QVYFYLFKLLRKCIL | 196 | Q92830 | |
| YIILQDLSFSCKYKV | 486 | P23352 | |
| LVEIILFCLLLYFYK | 181 | Q6P499 | |
| KKLTAYLDLNLDKCY | 151 | Q9Y287 | |
| NKCLELAEYLYAKIK | 481 | Q99259 | |
| ALYFACYEKLKKTLS | 146 | Q96A46 | |
| SLALFLIYAIVKEKY | 111 | Q9BY08 | |
| LDDLFLKRYASLLKY | 1351 | P42704 | |
| LEKSILLALVEKYKY | 16 | Q96H12 | |
| LLALVEKYKYVLECK | 21 | Q96H12 | |
| KDLFDCTLYVLLKYD | 211 | Q8N475 | |
| ILYLCYTDVMKLDLI | 231 | O95456 | |
| LLKCSIEYLYREETK | 706 | Q9Y2I7 | |
| LYYIDLKKSRSILKC | 221 | A4D1B5 | |
| DLLYLCLAAFEYKGK | 1286 | Q96HP0 | |
| SCRLFYFKLTDLYKK | 261 | Q16526 | |
| CKLAYYGFTKLLELF | 1296 | Q9Y4F3 | |
| NFKQVLKKYDLLCLY | 41 | O14958 | |
| LLEQYIYELLEKVCK | 61 | A6NC97 | |
| IYELLEKVCKLEKVY | 66 | A6NC97 | |
| DLLKKCYSAKASYLF | 351 | Q6ZQY3 | |
| YRALLVELTKKLTYC | 991 | Q8TDG4 | |
| ALLEKAYAKLLGCYE | 161 | Q9Y6Q1 | |
| KCYLSTKLALIAADY | 4476 | Q9NZJ4 | |
| LIEELRKCVDTYKYL | 26 | Q9UKD2 | |
| AKVLYLLELYCEDKQ | 2561 | O75691 | |
| KDEYEKFKLYLTIIL | 126 | A0PK00 | |
| KKFILLLEFHYYKCL | 476 | Q8WXH0 | |
| DEYEKFKLYLTIILI | 131 | Q9BXJ8 | |
| DYYLSAEILSKFKLL | 466 | Q8NE09 | |
| DEVKLLYLCATYKAL | 246 | Q96Q15 | |
| KILFKFCKDYALSYL | 546 | Q2Y0W8 | |
| IICFAIYESLKKYLK | 201 | Q9BSK2 | |
| TLKDLKLSYLDVYLI | 96 | C9JRZ8 | |
| YCKFALLLVLYTLVL | 11 | Q9NS84 | |
| VEYLKLKADGLIYCL | 236 | P43403 | |
| ELLFSLTQICIKYYK | 486 | Q9H900 | |
| LAALVYCVKKIYELY | 176 | P17152 | |
| ELYVIFKKELFLSCY | 801 | Q0IIM8 | |
| GLLLCFVLRYDNYKK | 276 | Q8TCT6 | |
| LLLFYLKKLTLFSTC | 561 | Q7Z404 | |
| VLIKVILDKYYFLCG | 51 | Q9NRS4 | |
| KIICLEIYYVVKGSL | 1041 | Q5SRE5 | |
| IIDFYLKYLVLEKLK | 686 | Q9GZR1 | |
| LDIDLKDIYYKIRCV | 81 | Q9BSR8 | |
| DILKFLFIYCLVLLA | 516 | Q9UL62 |